Predictors and Clinical Outcomes of Poor Platelet Recovery in Adult Dengue With Thrombocytopenia: A Multicenter, Prospective Study. (18th October 2019)

• Record Type: Journal Article
• Authors: Archuleta, Sophia; Chia, Po Ying; Wei, Yuan; Syed-Omar, Sharifah F; Low, Jenny G; Oh, Helen M; Fisher, Dale; Ponnampalavanar, Sasheela S L; Wijaya, Limin; Kamarulzaman, Adeeba; Lum, Lucy C S; Tambyah, Paul A; Leo, Yee-Sin; Lye, David C
• Is Part Of: Clinical infectious diseases. Volume 71:Number 2(2020)
• Page Start: 383
• Page End: 389
• Publication Date: 2019-10-18
• Subjects: dengue -- platelet transfusion -- platelet recovery; Communicable diseases -- Periodicals; 616.905
• DOI: 10.1093/cid/ciz850
• Languages: English
• ISSNs: 1058-4838

Abstract

Abstract: Background: Platelet transfusion is common in dengue patients with thrombocytopenia. We previously showed in a randomized clinical trial that prophylactic platelet transfusion did not reduce clinical bleeding. In this study, we aimed to characterize the predictors and clinical outcomes of poor platelet recovery in transfused and nontransfused participants. Methods: We analyzed patients from the Adult Dengue Platelet Study with laboratory-confirmed dengue with ≤20 000 platelets/μL and without persistent mild bleeding or any severe bleeding in a post hoc analysis. Poor platelet recovery was defined as a platelet count of ≤20 000/μL on Day 2. We recruited 372 participants from 5 acute care hospitals located in Singapore and Malaysia between 29 April 2010 and 9 December 2014. Of these, 188 were randomly assigned to the transfusion group and 184 to the control group. Results: Of 360 patients, 158 had poor platelet recovery. Age, white cell count, and day of illness at study enrollment were significant predictors of poor platelet recovery after adjustment for baseline characteristics and platelet transfusion. Patients with poor platelet recovery had longer hospitalizations but no significant difference in other clinical outcomes, regardless of transfusion. We found a significant interaction between platelet recovery and transfusion; patients with poor platelet recovery were more likely to bleed if given a prophylactic platelet transfusion (odds ratio 2.34, 95% confidence interval 1.18–4.63). Conclusions: Dengue patients with thrombocytopenia who were older or presented earlier and with lower white cell counts were more likely to have poor platelet recovery. In patients with poor platelet recovery, platelet transfusion does not improve outcomes and may actually increase the risk of bleeding. The mechanisms of poor platelet recovery need to be determined. Clinical Trials Registration: NCT01030211. Abstract : Dengue fever commonly results in thrombocytopenia. In this post hoc analysis, poor platelet recovery was associated with older ages, lower white cell counts, and earlier stages of illness at presentation, and resulted in longer hospitalizations.